Brain <scp> <sup>18</sup> F </scp> ‐fluorodeoxyglucose positron emission tomography: An efficient tool at the initial diagnosis of nonlesional late onset epilepsy
<sup>18</sup>F-FDG PET as part of the initial diagnosis of NLLOE patients may have a significant impact on both NLLOE diagnosis and cognitive prognosis. For almost half of NLLOE patients, a normal <sup>18</sup>F-FDG PET could help to exclude neurodegenerative and inflammatory epilepsy etiologies as well as future cognitive decline.
Authors
- Salomé Puisieux (ORCID: https://orcid.org/0000-0002-7453-0034)
- Louise Tyvaert (ORCID: https://orcid.org/0000-0003-0555-7150)
- Matthieu Doyen (ORCID: https://orcid.org/0000-0003-4193-5331)
- Sébastien Heyer
- Natacha Forthoffer
- Antoine Verger (ORCID: https://orcid.org/0000-0003-2194-0328)
Institutions
- Inserm (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Imagerie Adaptative Diagnostique et Interventionnelle (FR)
- Université de Lorraine (FR)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1111/epi.18328
- Citations
- 4
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.88